TOMY Company, Ltd. (TYO:7867)

Blueprint Medicines Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	42,594	56,163	64,279	66,455	65,424	63,656
Cash & Short-Term Investments	42,594	56,163	64,279	66,455	65,424	63,656
Cash Growth	-13.27%	-12.63%	-3.27%	1.58%	2.78%	35.41%
Receivables	29,909	29,301	25,040	20,710	20,125	17,985
Inventory	26,132	22,001	19,462	18,524	18,015	14,690
Other Current Assets	7,160	6,937	8,780	5,975	6,760	5,548
Total Current Assets	105,795	114,402	117,561	111,664	110,324	101,879
Property, Plant & Equipment	20,371	19,099	15,901	15,638	13,526	14,254
Long-Term Investments	6,777	6,215	5,517	5,002	5,134	4,855
Goodwill	10,345	11,140	13,135	15,616	15,988	15,902
Other Intangible Assets	12,487	12,787	12,465	10,115	9,902	9,455
Long-Term Deferred Tax Assets	2,377	2,125	1,671	1,483	1,215	1,267
Other Long-Term Assets	1	2	2	1	1	2
Total Assets	158,153	165,770	166,252	159,519	156,090	147,614
Accounts Payable	17,507	14,805	14,598	9,213	8,958	8,151
Accrued Expenses	9,549	11,738	11,146	8,197	8,429	7,028
Short-Term Debt	-	-	-	10,043	7,628	6,833
Current Portion of Long-Term Debt	3,234	3,472	6,183	8,901	8,834	8,064
Current Portion of Leases	3,481	3,506	3,274	3,198	2,686	2,332
Current Income Taxes Payable	10,320	14,676	14,945	8,838	9,924	7,284
Other Current Liabilities	4,861	2,736	3,576	4,666	3,468	2,603
Total Current Liabilities	48,952	50,933	53,722	53,056	49,927	42,295
Long-Term Debt	-	700	4,181	10,177	18,894	27,465
Long-Term Leases	3,034	3,124	3,259	3,669	1,626	1,549
Long-Term Deferred Tax Liabilities	485	498	857	903	1,242	724
Other Long-Term Liabilities	1,781	1,704	1,895	1,737	2,438	2,954
Total Liabilities	56,437	59,373	66,254	72,353	76,918	77,687
Common Stock	3,459	3,459	3,459	3,459	3,459	3,459
Additional Paid-In Capital	6,819	6,819	6,818	8,147	8,014	9,211
Retained Earnings	77,934	77,781	66,920	60,092	55,472	48,226
Treasury Stock	-9,578	-6,578	-3,980	-3,587	-3,374	-2,307
Comprehensive Income & Other	23,082	24,916	26,781	19,055	15,601	11,338
Total Common Equity	101,716	106,397	99,998	87,166	79,172	69,927
Shareholders' Equity	101,716	106,397	99,998	87,166	79,172	69,927
Total Liabilities & Equity	158,153	165,770	166,252	159,519	156,090	147,614
Total Debt	9,749	10,802	16,897	35,988	39,668	46,243
Net Cash (Debt)	32,845	45,361	47,382	30,467	25,756	17,413
Net Cash Growth	-2.64%	-4.26%	55.52%	18.29%	47.91%	26.85%
Net Cash Per Share	366.61	505.32	520.06	331.94	277.43	184.81
Filing Date Shares Outstanding	89.35	89.65	89.54	91.55	91.49	93.66
Total Common Shares Outstanding	89.35	89.65	90.54	91.55	91.62	93.66
Working Capital	56,843	63,469	63,839	58,608	60,397	59,584
Book Value Per Share	1138.39	1186.79	1104.42	952.06	864.10	746.63
Tangible Book Value	78,884	82,470	74,398	61,435	53,282	44,570
Tangible Book Value Per Share	882.86	919.90	821.68	671.02	581.53	475.89

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.